Archive
A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Biogen strikes deal with Versant-backed biotech to expand immune portfolio
Newly launched Dayra Therapeutics has agreed to identify for Biogen "oral macrocycle candidates" that go after "high-priority immunological targets."
A brain biotech’s top drug fails against MS
Shares of Contineum Therapeutics dipped by the double-digits late Thursday after investors learned of a clinical setback for a drug that’s also piqued Johnson & Johnson...